Improve walking speed through exercise
- Trial ID
- NCT07057219
- Official Title
- StepuP: Steps Against the Burden of Parkinson's Disease
- Goal
- Improve walking speed through exercise
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- The University of New South Wales
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease (PD)
- Interventions
- Exercise, Exercise
Plain-Language Summary
The trial aims to ease the walking and mobility problems many people with Parkinson's face, specifically targeting those with mild to moderate gait impairment. It tests a structured exercise program designed to build leg strength, balance, endurance and motor control, which can improve walking patterns and may promote neuroplasticity; the exercises are meant to complement, not replace, medications such as levodopa. Adults 18 and older with Parkinson's in Hoehn and Yahr stages I to III who have at least a mild gait score on the MDS-UPDRS, can walk at least one floor, and can give informed consent are eligible, while people with major medical risks for unsupervised exercise, severe depression or cognitive impairment, implanted DBS, or other significant exclusions are not.
Locations
- Neuroscience Research Australia, Randwick, New South Wales, Australia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exercise. The trial aims to ease the walking and mobility problems many people with Parkinson's face, specifically targeting those with mild to moderate gait impairment. It tests a structured exercise program designed to build leg strength, balance, endurance and motor control, which can improve walking patterns and may promote neuroplasticity; the exercises are meant to complement, not replace, medications such as levodopa. Adults 18 and older with Parkinson's in Hoehn and Yahr stages I to III who have at least a mild gait score on the MDS-UPDRS, can walk at least one floor, and can give informed consent are eligible, while people with major medical risks for unsupervised exercise, severe depression or cognitive impairment, implanted DBS, or other significant exclusions are not.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.